Bravecto 112.5 mg / 0.4 mL Solution is a Health Canada–registered veterinary drug (DIN 02454947) held by Intervet Canada Corp, containing Fluralaner. Health Canada lists its status as Marketed (status date 16 Feb 2018). Nexara Health has matched 57 registrations of Fluralaner across 8 other regulated markets.
Health Canada registration
| DIN | 02454947 |
|---|---|
| Brand name | Bravecto |
| Active ingredient | Fluralaner |
| Strength | 112.5 mg / 0.4 mL |
| Dosage form | Solution |
| Route | Topical |
| Company | Intervet Canada Corp |
| Status | Marketed — 16 Feb 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Fluralaner registered in other markets
57 registrations of the same molecule in 8 national registries outside Canada (first 33 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Bravecto | Intervet International B.V. | 150 mg/ml | pulver og solvens til injektionsvæske, suspension | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto | Intervet International B.V. | 250 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto | Intervet International B.V. | 500 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto | Intervet International B.V. | 1000 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto | Intervet International B.V. | 1400 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto | Intervet International B.V. | 112,5 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto til hunde >10-20 kg | Intervet International B.V. | 500 mg | spot-on, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Bravecto til hunde >20-40 kg | Intervet International B.V. | 1000 mg | spot-on, opløsning | Central | Laegemiddelstyrelsen |
| European Union (EMA) | Bravecto | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Exzolt | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Fluralaner Intervet | — | Authorised | EMA centrally authorised | ||
| Finland | Bravecto | Intervet International B.V. | 112.5 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 250 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 500 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 1000 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 1400 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 112.5 mg | paikallisvaleluliuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 250 mg | paikallisvaleluliuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bravecto | Intervet International B.V. | 500 mg | paikallisvaleluliuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Hong Kong | Bravecto Chewable Tablets For Large Dogs 1000mg (Vet) | Merck Sharp & Dohme (Asia) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Bravecto Chewable Tablets For Medium-Sized Dogs 500mg (Vet) | Merck Sharp & Dohme (Asia) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Bravecto Chewable Tablets For Small Dogs 250mg (Vet) | Merck Sharp & Dohme (Asia) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Bravecto Chewable Tablets For Very Large Dogs 1400mg (Vet) | Merck Sharp & Dohme (Asia) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Bravecto Chewable Tablets For Very Small Dogs 112.5mg (Vet) | Merck Sharp & Dohme (Asia) Ltd | Registered | DH Drug Office | ||
| Iceland | Bravecto | Icepharma - óskráð | 500 mg | tuggutfl | 0 | Lyfjastofnun lyfjaverdskra |
| Malaysia | Exzolt 10mg/mL Solution For Use In Drinking Water For Chickens | Intervet (m) Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Bravecto | Intervet International B.V. | 112,5 mg | Roztwór do nakrapiania | URPL RPL | |
| Poland | Exzolt | Intervet International B.V. | 10 mg/ml | Roztwór do podania w wodzie do picia | URPL RPL | |
| Poland | Fluralaner Intervet | Intervet International B.V. | 200 mg | Tabletka do rozgryzania i żucia | Bezterminowe | URPL RPL |
| United States | Fluralaner | Wisdom Pharmaceutical Co.,Ltd. | Powder | FDA NDC | ||
| United States | Fluralaner | Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Fluralaner | Nissan Chemical Corporation | Granule | FDA NDC | ||
| United States | Fluralaner | Hisun Pharmaceutical (Nantong) Co., Ltd. | Powder | FDA NDC |
See every manufacturer of Fluralaner worldwide →
Regulator price references for Fluralaner
Published list or reimbursement prices for Fluralaner presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Bravecto | 500mg | pakki | 8,300.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02454912 | Bravecto | Intervet Canada Corp | 112.5 mg / 0.4 mL | Solution |
| 02454998 | Bravecto | Intervet Canada Corp | 1400 mg / 5 mL | Solution |
| 02454963 | Bravecto | Intervet Canada Corp | 500 mg / 1.79 mL | Solution |
| 02454955 | Bravecto | Intervet Canada Corp | 250 mg / 0.89 mL | Solution |
| 02425076 | Bravecto | Intervet Canada Corp | 250 mg | Tablet (Chewable) |
| 02454971 | Bravecto | Intervet Canada Corp | 1000 mg / 3.57 mL | Solution |
| 02425068 | Bravecto | Intervet Canada Corp | 112.5 mg | Tablet (Chewable) |
| 02425092 | Bravecto | Intervet Canada Corp | 1000 mg | Tablet (Chewable) |
| 02425106 | Bravecto | Intervet Canada Corp | 1400 mg | Tablet (Chewable) |
| 02454939 | Bravecto | Intervet Canada Corp | 500 mg / 1.79 mL | Solution |
| 02425084 | Bravecto | Intervet Canada Corp | 500 mg | Tablet (Chewable) |
| 02454920 | Bravecto | Intervet Canada Corp | 250 mg / 0.89 mL | Solution |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Bravecto (DIN 02454947) marketed in Canada?
Yes. Health Canada lists DIN 02454947 as Marketed as of 16 Feb 2018.
Who holds the Canadian licence for this product?
Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.
Is Fluralaner registered outside Canada?
Yes — Nexara Health has matched 57 registrations in 8 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02454947, status date 2018-02-16; national medicine registries: DH Drug Office, EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02454947, status date 2018-02-16; national medicine registries: DH Drug Office, EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02454947, status date 2018-02-16; national medicine registries: DH Drug Office, EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.